Annual Cancer Immunotherapy Conference 2013

ARROWHEAD'S 2nd Annual Cancer Immunotherapy Conference will provide a comprehensive review of cutting edge research and development in two areas:
• Cancer Stem Cells as a new category of Targets for Immune Intervention for solid and hematological malignancies
• Hematopoietic Stem Cell and T Cell Engineering for cancer immunotherapy

The conference is bringing together leading scientists and C-Level executives from across the globe to present research, case studies and viewpoints on topics related to stem cells and cancer immunotherapy.
Conference Tracks

There will be two sequential tracks focused on the following topics:
• Tumor initiating and cancer stem cells in solid tumors: novel targets and their immunotherapeutic potential
• Novel approaches to re-direct the immune system against cancer, by engineering hematological stem cells and memory T cells

Speakers to Date Include
Adrian Bot, MD, Ph.D.,
Maurizio Chiriva-Internati, DBSc, Ph.D.,
Andrew Cornforth, Ph.D.,
Soldano Ferrone, MD, Ph.D.,
Kenneth Geles, Ph.D.,
Philip D. Greenberg, MD
Richard C. Koya, MD, Ph.D.,
and many more.